FR2705966B1 - Compositions antimousse utiles notamment pour le traitement de troubles gastriques. - Google Patents

Compositions antimousse utiles notamment pour le traitement de troubles gastriques.

Info

Publication number
FR2705966B1
FR2705966B1 FR9306695A FR9306695A FR2705966B1 FR 2705966 B1 FR2705966 B1 FR 2705966B1 FR 9306695 A FR9306695 A FR 9306695A FR 9306695 A FR9306695 A FR 9306695A FR 2705966 B1 FR2705966 B1 FR 2705966B1
Authority
FR
France
Prior art keywords
treatment
compositions useful
gastric disorders
antifoam compositions
antifoam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9306695A
Other languages
English (en)
Other versions
FR2705966A1 (fr
Inventor
Briquet Francois Jean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Silicones Belgium SPRL
Dow Corning France SAS
Original Assignee
Dow Corning SA
Dow Corning France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning SA, Dow Corning France SAS filed Critical Dow Corning SA
Priority to FR9306695A priority Critical patent/FR2705966B1/fr
Priority to GB9410694A priority patent/GB2279009B/en
Priority to US08/251,436 priority patent/US5458886A/en
Priority to DE4419607A priority patent/DE4419607A1/de
Priority to JP6123946A priority patent/JPH07166062A/ja
Publication of FR2705966A1 publication Critical patent/FR2705966A1/fr
Application granted granted Critical
Publication of FR2705966B1 publication Critical patent/FR2705966B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/02—Foam dispersion or prevention
    • B01D19/04—Foam dispersion or prevention by addition of chemical substances
    • B01D19/0404—Foam dispersion or prevention by addition of chemical substances characterised by the nature of the chemical substance
    • B01D19/0409—Foam dispersion or prevention by addition of chemical substances characterised by the nature of the chemical substance compounds containing Si-atoms
FR9306695A 1993-06-04 1993-06-04 Compositions antimousse utiles notamment pour le traitement de troubles gastriques. Expired - Fee Related FR2705966B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR9306695A FR2705966B1 (fr) 1993-06-04 1993-06-04 Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
GB9410694A GB2279009B (en) 1993-06-04 1994-05-27 Organopolysiloxane antifoam compositions
US08/251,436 US5458886A (en) 1993-06-04 1994-05-31 Antifoam compositions
DE4419607A DE4419607A1 (de) 1993-06-04 1994-06-03 Schaumhemmende Zusammensetzungen
JP6123946A JPH07166062A (ja) 1993-06-04 1994-06-06 自由流動性の粒状組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9306695A FR2705966B1 (fr) 1993-06-04 1993-06-04 Compositions antimousse utiles notamment pour le traitement de troubles gastriques.

Publications (2)

Publication Number Publication Date
FR2705966A1 FR2705966A1 (fr) 1994-12-09
FR2705966B1 true FR2705966B1 (fr) 1995-08-25

Family

ID=9447758

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9306695A Expired - Fee Related FR2705966B1 (fr) 1993-06-04 1993-06-04 Compositions antimousse utiles notamment pour le traitement de troubles gastriques.

Country Status (5)

Country Link
US (1) US5458886A (fr)
JP (1) JPH07166062A (fr)
DE (1) DE4419607A1 (fr)
FR (1) FR2705966B1 (fr)
GB (1) GB2279009B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576296B2 (en) 1995-03-14 2009-08-18 Battelle Energy Alliance, Llc Thermal synthesis apparatus
US5749937A (en) * 1995-03-14 1998-05-12 Lockheed Idaho Technologies Company Fast quench reactor and method
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US6395197B1 (en) 1999-12-21 2002-05-28 Bechtel Bwxt Idaho Llc Hydrogen and elemental carbon production from natural gas and other hydrocarbons
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
EP1541133B1 (fr) * 2003-12-09 2005-08-10 Helm AG Formulation pharmaceutique de valaciclovir
US7354561B2 (en) 2004-11-17 2008-04-08 Battelle Energy Alliance, Llc Chemical reactor and method for chemically converting a first material into a second material
US8591821B2 (en) 2009-04-23 2013-11-26 Battelle Energy Alliance, Llc Combustion flame-plasma hybrid reactor systems, and chemical reactant sources
JP2011173786A (ja) * 2010-02-23 2011-09-08 Dow Global Technologies Llc セメントスラリーのためのレオロジー調整剤
CN101804199B (zh) * 2010-03-30 2012-07-25 四川健能制药有限公司 一种用于消化道的药物组合物及其应用
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
CA2876062C (fr) 2012-06-12 2017-09-12 The Procter & Gamble Company Forme posologique effervescente
JP6248262B2 (ja) * 2014-07-08 2017-12-20 サンノプコ株式会社 粉末消泡剤
MA41620A (fr) 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composition pharmaceutique comprenant de la siméthicone et de l'otilonium
US11433051B2 (en) * 2016-02-16 2022-09-06 Siga Technologies, Inc. ST-246 (tecovirimat monohydrate) suspension formulations
WO2023089432A1 (fr) 2021-11-16 2023-05-25 Johnson & Johnson Consumer Inc. Formes posologiques personnalisables contenant de la siméthicone

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441098A (en) * 1946-09-09 1948-05-04 Corning Glass Works Methyl siloxane polymers and method of preparation
GB985546A (en) * 1960-04-01 1965-03-10 Berk Pharmaceuticals Ltd Therapeutic compositions comprising polysiloxanes
DE1545185C3 (de) * 1961-10-18 1974-06-20 Wacker-Chemie Gmbh, 8000 Muenchen Verfahren zur Herstellung von Antischaummitteln auf Poly siloxanbasis
GB1051687A (fr) * 1963-05-06
GB1051688A (fr) * 1963-05-06
GB1079832A (en) * 1963-06-12 1967-08-16 Midland Silicones Ltd Improvements in or relating to siloxane antifoam compositions
IL26885A (en) * 1965-12-06 1970-10-30 Smith Kline French Lab Pharmaceutical silicone compositions
NL136759C (fr) * 1966-02-16
US3560403A (en) * 1967-08-11 1971-02-02 Union Carbide Corp Persistent antifoam compositions and methods of making same utilizing dialkylamino organosilicone fluids
US3560401A (en) * 1967-08-11 1971-02-02 Union Carbide Corp Persistent antifoam compositions and methods of making same utilizing basic materials
US3767794A (en) * 1969-11-21 1973-10-23 Richardson Merrell Inc Antifoam preparations and method of preparing same
CA921354A (en) * 1970-10-14 1973-02-20 Dow Corning Limited Siloxane compositions
US4115553A (en) * 1973-12-10 1978-09-19 Armour Pharmaceutical Company Antacid tablets
FR2351156A1 (fr) * 1976-05-11 1977-12-09 Rhone Poulenc Ind Compositions organosiliciques presentant une activite antimousse stable
US4110300A (en) * 1976-11-12 1978-08-29 Toray Silicone Company, Ltd. Self-extinguishing silicone rubber compositions
CA1139221A (fr) * 1978-10-10 1983-01-11 Vijay B. Surpuriya Anti-acide
ATE10339T1 (de) * 1981-06-30 1984-12-15 Siparpharma Sa Essbare arzneimittelform einer stoffzusammensetzung die fluessiges dimethylpolysiloxan enthaelt.
DE3713267C3 (de) * 1987-04-18 1998-10-01 Minnesota Mining & Mfg Flammwidrige Silikonkautschuk-Masse und ihre Verwendung
US4906478A (en) * 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate

Also Published As

Publication number Publication date
DE4419607A1 (de) 1994-12-08
JPH07166062A (ja) 1995-06-27
GB2279009B (en) 1997-08-27
GB9410694D0 (en) 1994-07-13
US5458886A (en) 1995-10-17
FR2705966A1 (fr) 1994-12-09
GB2279009A (en) 1994-12-21

Similar Documents

Publication Publication Date Title
FR2705966B1 (fr) Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
MA23143A1 (fr) Procede pour la preparation de compositions vaccinantes .
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
FR12C0077I2 (fr) Composition pour le traitement des condylomes génitaux
FR2690855B1 (fr) Adsorbants pour l'elimination de hcl et procede pour leur production et leur utilisation.
FR2704743B1 (fr) Dispositif pour réduire la sensation de douleur.
FR2685206B1 (fr) Dispositif de drainage implantable pour le traitement de l'hydrocephalie.
FR2699065B1 (fr) Vis autocompressive pour le traitement des fractures épiphysaires et/ou ostéo-chondrales.
FR2578421B1 (fr) Compositions pharmaceutiques utiles pour le traitement des troubles de la memoire
FR2663044B1 (fr) Appareil pour le traitement de surfaces.
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
FR2684554B1 (fr) Medicaments pour le traitement d'etats inflammatoires ou pour l'analgesie.
FR2715060B1 (fr) Dispositif pour l'ozonisation de petites zones ou surfaces à des fins thérapeutiques.
FR2694575B1 (fr) Procede pour le traitement de revetements en mcralz.
FR2758465B1 (fr) Composition pour le traitement de l'amiante
DZ2012A1 (fr) Benzamides pour le traitement de dégénérescences neurologiques.
FR2728142B1 (fr) Composition pour le traitement anti-germinatif de tubercules ou de bulbes ; procede de traitement
DZ1988A1 (fr) Thérapie de combinaison pour le traitement de l'hiv.
FR2658419B1 (fr) Medicament pour le traitement de la dermatite.
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
FR2715656B1 (fr) Procédé de préparation d'anhydride citraconique.
FR2536995B1 (fr) Composition pour le traitement de l'arthrite
FR2680123B1 (fr) Procede de traitement de residus fortement polluants pour l'environnement.
FR2544614B1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
MA26908A1 (fr) S-methyl-dihydro-ziprasidone pour le traitement de troubles psychiatriques et oculaires

Legal Events

Date Code Title Description
ST Notification of lapse